世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
創薬のアウトソーシング - 世界市場シェアとランキング、全体売上高と需要予測 2024-2030Outsourcing Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 創薬アウトソーシングの世界市場規模は2023年に100万米ドルと推定され、2024-2030年の予測期間中のCAGRは%で、2030年には100万米ドルに再調整されると予測されている。 世界の医薬品市場は2022年に1,475億米ドル... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー創薬アウトソーシングの世界市場規模は2023年に100万米ドルと推定され、2024-2030年の予測期間中のCAGRは%で、2030年には100万米ドルに再調整されると予測されている。世界の医薬品市場は2022年に1,475億米ドルとなり、今後6年間のCAGRは5％で成長する。医薬品市場には化学医薬品と生物学的製剤が含まれる。生物製剤は2022年に3810億米ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間＆政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要としている患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の流行はワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調している。 レポートの範囲 本レポートは、Outsourcing Drug Discoveryの世界市場を包括的に紹介することを目的としており、地域別・国別、タイプ別、用途別のOutsourcing Drug Discoveryの分析とともに、総売上高、主要企業の市場シェア、ランキングに焦点を当てています。 創薬アウトソーシング市場規模、推計、予測は、2023年を基準年とし、2019年から2030年までの期間の履歴データと予測データを売上高（百万ドル）で提供します。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、創薬アウトソーシングに関する十分な情報に基づいたビジネス上の意思決定を行えるよう支援します。 市場区分 企業別 アルバニー・モレキュラー・リサーチ社 エボテックAG アスクレピア メドケム ソリューションズ オーレリア・バイオサイエンス社 Axxam SpA バイオドゥーロ チャールズリバーラボラトリーズ チャーンウッド・モレキュラー クレアジェン・バイオサイエンス社 クラウン・バイオサイエンス サイプロテックスPLC、エボテックAG会社 ドメインレックス ナノシン社 オロン・リチェルカ・バイオサイエンス ファーマロン社 TCGライフサイエンス社 ビババイオテック 武西アプリテックLtd. タイプ別セグメント 化学サービス 生物学サービス ハイスループットスクリーニングサービス リード最適化サービス アプリケーション別セグメント 一般用医薬品 医薬品 地域別 北米 米国 カナダ ヨーロッパ ドイツ フランス 英国 イタリア ロシア アジア太平洋 中国 日本 韓国 中国 台湾 東南アジア インド ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 各章の概要 第1章：報告書のスコープ、世界の総市場規模を紹介。本章ではまた、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章：創薬アウトソーシングメーカーの競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。 第3章：タイプ別に様々な市場セグメントを分析し、各市場セグメントの市場規模と発展可能性を網羅し、読者が様々な市場セグメントにおけるブルーオーシャン市場を見つけるのに役立ちます。 第4章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展の可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。 第5章：地域レベルでの創薬アウトソーシングの収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、市場規模を紹介しています。 第6章 国別創薬アウトソーシングの収益。各国・地域のタイプ別、用途別のシグメイトデータを提供しています。 第7章：主要企業のプロファイルを提供し、製品収益、売上総利益率、製品紹介、最近の開発など、市場における主要企業の基本的な状況を詳細に紹介する。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 Outsourcing Drug Discovery Product Introduction 1.2 Global Outsourcing Drug Discovery Market Size Forecast 1.3 Outsourcing Drug Discovery Market Trends & Drivers 1.3.1 Outsourcing Drug Discovery Industry Trends 1.3.2 Outsourcing Drug Discovery Market Drivers & Opportunity 1.3.3 Outsourcing Drug Discovery Market Challenges 1.3.4 Outsourcing Drug Discovery Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Outsourcing Drug Discovery Players Revenue Ranking (2023) 2.2 Global Outsourcing Drug Discovery Revenue by Company (2019-2024) 2.3 Key Companies Outsourcing Drug Discovery Manufacturing Base Distribution and Headquarters 2.4 Key Companies Outsourcing Drug Discovery Product Offered 2.5 Key Companies Time to Begin Mass Production of Outsourcing Drug Discovery 2.6 Outsourcing Drug Discovery Market Competitive Analysis 2.6.1 Outsourcing Drug Discovery Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Outsourcing Drug Discovery Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Outsourcing Drug Discovery as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Chemistry Services 3.1.2 Biology Services 3.1.3 High Throughput Screening Services 3.1.4 Lead Optimization Services 3.2 Global Outsourcing Drug Discovery Sales Value by Type 3.2.1 Global Outsourcing Drug Discovery Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Outsourcing Drug Discovery Sales Value, by Type (2019-2030) 3.2.3 Global Outsourcing Drug Discovery Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 OTC 4.1.2 Rx 4.2 Global Outsourcing Drug Discovery Sales Value by Application 4.2.1 Global Outsourcing Drug Discovery Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Outsourcing Drug Discovery Sales Value, by Application (2019-2030) 4.2.3 Global Outsourcing Drug Discovery Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Outsourcing Drug Discovery Sales Value by Region 5.1.1 Global Outsourcing Drug Discovery Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Outsourcing Drug Discovery Sales Value by Region (2019-2024) 5.1.3 Global Outsourcing Drug Discovery Sales Value by Region (2025-2030) 5.1.4 Global Outsourcing Drug Discovery Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Outsourcing Drug Discovery Sales Value, 2019-2030 5.2.2 North America Outsourcing Drug Discovery Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Outsourcing Drug Discovery Sales Value, 2019-2030 5.3.2 Europe Outsourcing Drug Discovery Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Outsourcing Drug Discovery Sales Value, 2019-2030 5.4.2 Asia Pacific Outsourcing Drug Discovery Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Outsourcing Drug Discovery Sales Value, 2019-2030 5.5.2 South America Outsourcing Drug Discovery Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Outsourcing Drug Discovery Sales Value, 2019-2030 5.6.2 Middle East & Africa Outsourcing Drug Discovery Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Outsourcing Drug Discovery Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Outsourcing Drug Discovery Sales Value 6.3 United States 6.3.1 United States Outsourcing Drug Discovery Sales Value, 2019-2030 6.3.2 United States Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Outsourcing Drug Discovery Sales Value, 2019-2030 6.4.2 Europe Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Outsourcing Drug Discovery Sales Value, 2019-2030 6.5.2 China Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.5.3 China Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Outsourcing Drug Discovery Sales Value, 2019-2030 6.6.2 Japan Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Outsourcing Drug Discovery Sales Value, 2019-2030 6.7.2 South Korea Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Outsourcing Drug Discovery Sales Value, 2019-2030 6.8.2 Southeast Asia Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Outsourcing Drug Discovery Sales Value, 2019-2030 6.9.2 India Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.9.3 India Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Albany Molecular Research, Inc. 7.1.1 Albany Molecular Research, Inc. Profile 7.1.2 Albany Molecular Research, Inc. Main Business 7.1.3 Albany Molecular Research, Inc. Outsourcing Drug Discovery Products, Services and Solutions 7.1.4 Albany Molecular Research, Inc. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.1.5 Albany Molecular Research, Inc. Recent Developments 7.2 Evotec AG 7.2.1 Evotec AG Profile 7.2.2 Evotec AG Main Business 7.2.3 Evotec AG Outsourcing Drug Discovery Products, Services and Solutions 7.2.4 Evotec AG Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.2.5 Evotec AG Recent Developments 7.3 Asclepia MedChem Solutions 7.3.1 Asclepia MedChem Solutions Profile 7.3.2 Asclepia MedChem Solutions Main Business 7.3.3 Asclepia MedChem Solutions Outsourcing Drug Discovery Products, Services and Solutions 7.3.4 Asclepia MedChem Solutions Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.3.5 Aurelia Bioscience Ltd Recent Developments 7.4 Aurelia Bioscience Ltd 7.4.1 Aurelia Bioscience Ltd Profile 7.4.2 Aurelia Bioscience Ltd Main Business 7.4.3 Aurelia Bioscience Ltd Outsourcing Drug Discovery Products, Services and Solutions 7.4.4 Aurelia Bioscience Ltd Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.4.5 Aurelia Bioscience Ltd Recent Developments 7.5 Axxam SpA 7.5.1 Axxam SpA Profile 7.5.2 Axxam SpA Main Business 7.5.3 Axxam SpA Outsourcing Drug Discovery Products, Services and Solutions 7.5.4 Axxam SpA Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.5.5 Axxam SpA Recent Developments 7.6 BioDuro 7.6.1 BioDuro Profile 7.6.2 BioDuro Main Business 7.6.3 BioDuro Outsourcing Drug Discovery Products, Services and Solutions 7.6.4 BioDuro Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.6.5 BioDuro Recent Developments 7.7 Charles River Laboratories, Inc. 7.7.1 Charles River Laboratories, Inc. Profile 7.7.2 Charles River Laboratories, Inc. Main Business 7.7.3 Charles River Laboratories, Inc. Outsourcing Drug Discovery Products, Services and Solutions 7.7.4 Charles River Laboratories, Inc. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.7.5 Charles River Laboratories, Inc. Recent Developments 7.8 Charnwood Molecular 7.8.1 Charnwood Molecular Profile 7.8.2 Charnwood Molecular Main Business 7.8.3 Charnwood Molecular Outsourcing Drug Discovery Products, Services and Solutions 7.8.4 Charnwood Molecular Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.8.5 Charnwood Molecular Recent Developments 7.9 CreaGen Biosciences, Inc. 7.9.1 CreaGen Biosciences, Inc. Profile 7.9.2 CreaGen Biosciences, Inc. Main Business 7.9.3 CreaGen Biosciences, Inc. Outsourcing Drug Discovery Products, Services and Solutions 7.9.4 CreaGen Biosciences, Inc. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.9.5 CreaGen Biosciences, Inc. Recent Developments 7.10 Crown Bioscience 7.10.1 Crown Bioscience Profile 7.10.2 Crown Bioscience Main Business 7.10.3 Crown Bioscience Outsourcing Drug Discovery Products, Services and Solutions 7.10.4 Crown Bioscience Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.10.5 Crown Bioscience Recent Developments 7.11 Cyprotex PLC, an Evotec AG Company 7.11.1 Cyprotex PLC, an Evotec AG Company Profile 7.11.2 Cyprotex PLC, an Evotec AG Company Main Business 7.11.3 Cyprotex PLC, an Evotec AG Company Outsourcing Drug Discovery Products, Services and Solutions 7.11.4 Cyprotex PLC, an Evotec AG Company Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.11.5 Cyprotex PLC, an Evotec AG Company Recent Developments 7.12 Domainex 7.12.1 Domainex Profile 7.12.2 Domainex Main Business 7.12.3 Domainex Outsourcing Drug Discovery Products, Services and Solutions 7.12.4 Domainex Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.12.5 Domainex Recent Developments 7.13 Nanosyn, Inc. 7.13.1 Nanosyn, Inc. Profile 7.13.2 Nanosyn, Inc. Main Business 7.13.3 Nanosyn, Inc. Outsourcing Drug Discovery Products, Services and Solutions 7.13.4 Nanosyn, Inc. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.13.5 Nanosyn, Inc. Recent Developments 7.14 Olon Ricerca Biosciences 7.14.1 Olon Ricerca Biosciences Profile 7.14.2 Olon Ricerca Biosciences Main Business 7.14.3 Olon Ricerca Biosciences Outsourcing Drug Discovery Products, Services and Solutions 7.14.4 Olon Ricerca Biosciences Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.14.5 Olon Ricerca Biosciences Recent Developments 7.15 Pharmaron, Inc. 7.15.1 Pharmaron, Inc. Profile 7.15.2 Pharmaron, Inc. Main Business 7.15.3 Pharmaron, Inc. Outsourcing Drug Discovery Products, Services and Solutions 7.15.4 Pharmaron, Inc. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.15.5 Pharmaron, Inc. Recent Developments 7.16 TCG Lifesciences Pvt Ltd. 7.16.1 TCG Lifesciences Pvt Ltd. Profile 7.16.2 TCG Lifesciences Pvt Ltd. Main Business 7.16.3 TCG Lifesciences Pvt Ltd. Outsourcing Drug Discovery Products, Services and Solutions 7.16.4 TCG Lifesciences Pvt Ltd. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.16.5 TCG Lifesciences Pvt Ltd. Recent Developments 7.17 Viva Biotech, Ltd. 7.17.1 Viva Biotech, Ltd. Profile 7.17.2 Viva Biotech, Ltd. Main Business 7.17.3 Viva Biotech, Ltd. Outsourcing Drug Discovery Products, Services and Solutions 7.17.4 Viva Biotech, Ltd. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.17.5 Viva Biotech, Ltd. Recent Developments 7.18 WuXi AppTec Co. Ltd. 7.18.1 WuXi AppTec Co. Ltd. Profile 7.18.2 WuXi AppTec Co. Ltd. Main Business 7.18.3 WuXi AppTec Co. Ltd. Outsourcing Drug Discovery Products, Services and Solutions 7.18.4 WuXi AppTec Co. Ltd. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.18.5 WuXi AppTec Co. Ltd. Recent Developments 8 Industry Chain Analysis 8.1 Outsourcing Drug Discovery Industrial Chain 8.2 Outsourcing Drug Discovery Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Outsourcing Drug Discovery Sales Model 8.5.2 Sales Channel 8.5.3 Outsourcing Drug Discovery Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Outsourcing Drug Discovery was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. Table of Contents1 Market Overview1.1 Outsourcing Drug Discovery Product Introduction 1.2 Global Outsourcing Drug Discovery Market Size Forecast 1.3 Outsourcing Drug Discovery Market Trends & Drivers 1.3.1 Outsourcing Drug Discovery Industry Trends 1.3.2 Outsourcing Drug Discovery Market Drivers & Opportunity 1.3.3 Outsourcing Drug Discovery Market Challenges 1.3.4 Outsourcing Drug Discovery Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Outsourcing Drug Discovery Players Revenue Ranking (2023) 2.2 Global Outsourcing Drug Discovery Revenue by Company (2019-2024) 2.3 Key Companies Outsourcing Drug Discovery Manufacturing Base Distribution and Headquarters 2.4 Key Companies Outsourcing Drug Discovery Product Offered 2.5 Key Companies Time to Begin Mass Production of Outsourcing Drug Discovery 2.6 Outsourcing Drug Discovery Market Competitive Analysis 2.6.1 Outsourcing Drug Discovery Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Outsourcing Drug Discovery Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Outsourcing Drug Discovery as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Chemistry Services 3.1.2 Biology Services 3.1.3 High Throughput Screening Services 3.1.4 Lead Optimization Services 3.2 Global Outsourcing Drug Discovery Sales Value by Type 3.2.1 Global Outsourcing Drug Discovery Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Outsourcing Drug Discovery Sales Value, by Type (2019-2030) 3.2.3 Global Outsourcing Drug Discovery Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 OTC 4.1.2 Rx 4.2 Global Outsourcing Drug Discovery Sales Value by Application 4.2.1 Global Outsourcing Drug Discovery Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Outsourcing Drug Discovery Sales Value, by Application (2019-2030) 4.2.3 Global Outsourcing Drug Discovery Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Outsourcing Drug Discovery Sales Value by Region 5.1.1 Global Outsourcing Drug Discovery Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Outsourcing Drug Discovery Sales Value by Region (2019-2024) 5.1.3 Global Outsourcing Drug Discovery Sales Value by Region (2025-2030) 5.1.4 Global Outsourcing Drug Discovery Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Outsourcing Drug Discovery Sales Value, 2019-2030 5.2.2 North America Outsourcing Drug Discovery Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Outsourcing Drug Discovery Sales Value, 2019-2030 5.3.2 Europe Outsourcing Drug Discovery Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Outsourcing Drug Discovery Sales Value, 2019-2030 5.4.2 Asia Pacific Outsourcing Drug Discovery Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Outsourcing Drug Discovery Sales Value, 2019-2030 5.5.2 South America Outsourcing Drug Discovery Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Outsourcing Drug Discovery Sales Value, 2019-2030 5.6.2 Middle East & Africa Outsourcing Drug Discovery Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Outsourcing Drug Discovery Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Outsourcing Drug Discovery Sales Value 6.3 United States 6.3.1 United States Outsourcing Drug Discovery Sales Value, 2019-2030 6.3.2 United States Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Outsourcing Drug Discovery Sales Value, 2019-2030 6.4.2 Europe Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Outsourcing Drug Discovery Sales Value, 2019-2030 6.5.2 China Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.5.3 China Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Outsourcing Drug Discovery Sales Value, 2019-2030 6.6.2 Japan Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Outsourcing Drug Discovery Sales Value, 2019-2030 6.7.2 South Korea Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Outsourcing Drug Discovery Sales Value, 2019-2030 6.8.2 Southeast Asia Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Outsourcing Drug Discovery Sales Value, 2019-2030 6.9.2 India Outsourcing Drug Discovery Sales Value by Type (%), 2023 VS 2030 6.9.3 India Outsourcing Drug Discovery Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Albany Molecular Research, Inc. 7.1.1 Albany Molecular Research, Inc. Profile 7.1.2 Albany Molecular Research, Inc. Main Business 7.1.3 Albany Molecular Research, Inc. Outsourcing Drug Discovery Products, Services and Solutions 7.1.4 Albany Molecular Research, Inc. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.1.5 Albany Molecular Research, Inc. Recent Developments 7.2 Evotec AG 7.2.1 Evotec AG Profile 7.2.2 Evotec AG Main Business 7.2.3 Evotec AG Outsourcing Drug Discovery Products, Services and Solutions 7.2.4 Evotec AG Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.2.5 Evotec AG Recent Developments 7.3 Asclepia MedChem Solutions 7.3.1 Asclepia MedChem Solutions Profile 7.3.2 Asclepia MedChem Solutions Main Business 7.3.3 Asclepia MedChem Solutions Outsourcing Drug Discovery Products, Services and Solutions 7.3.4 Asclepia MedChem Solutions Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.3.5 Aurelia Bioscience Ltd Recent Developments 7.4 Aurelia Bioscience Ltd 7.4.1 Aurelia Bioscience Ltd Profile 7.4.2 Aurelia Bioscience Ltd Main Business 7.4.3 Aurelia Bioscience Ltd Outsourcing Drug Discovery Products, Services and Solutions 7.4.4 Aurelia Bioscience Ltd Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.4.5 Aurelia Bioscience Ltd Recent Developments 7.5 Axxam SpA 7.5.1 Axxam SpA Profile 7.5.2 Axxam SpA Main Business 7.5.3 Axxam SpA Outsourcing Drug Discovery Products, Services and Solutions 7.5.4 Axxam SpA Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.5.5 Axxam SpA Recent Developments 7.6 BioDuro 7.6.1 BioDuro Profile 7.6.2 BioDuro Main Business 7.6.3 BioDuro Outsourcing Drug Discovery Products, Services and Solutions 7.6.4 BioDuro Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.6.5 BioDuro Recent Developments 7.7 Charles River Laboratories, Inc. 7.7.1 Charles River Laboratories, Inc. Profile 7.7.2 Charles River Laboratories, Inc. Main Business 7.7.3 Charles River Laboratories, Inc. Outsourcing Drug Discovery Products, Services and Solutions 7.7.4 Charles River Laboratories, Inc. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.7.5 Charles River Laboratories, Inc. Recent Developments 7.8 Charnwood Molecular 7.8.1 Charnwood Molecular Profile 7.8.2 Charnwood Molecular Main Business 7.8.3 Charnwood Molecular Outsourcing Drug Discovery Products, Services and Solutions 7.8.4 Charnwood Molecular Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.8.5 Charnwood Molecular Recent Developments 7.9 CreaGen Biosciences, Inc. 7.9.1 CreaGen Biosciences, Inc. Profile 7.9.2 CreaGen Biosciences, Inc. Main Business 7.9.3 CreaGen Biosciences, Inc. Outsourcing Drug Discovery Products, Services and Solutions 7.9.4 CreaGen Biosciences, Inc. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.9.5 CreaGen Biosciences, Inc. Recent Developments 7.10 Crown Bioscience 7.10.1 Crown Bioscience Profile 7.10.2 Crown Bioscience Main Business 7.10.3 Crown Bioscience Outsourcing Drug Discovery Products, Services and Solutions 7.10.4 Crown Bioscience Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.10.5 Crown Bioscience Recent Developments 7.11 Cyprotex PLC, an Evotec AG Company 7.11.1 Cyprotex PLC, an Evotec AG Company Profile 7.11.2 Cyprotex PLC, an Evotec AG Company Main Business 7.11.3 Cyprotex PLC, an Evotec AG Company Outsourcing Drug Discovery Products, Services and Solutions 7.11.4 Cyprotex PLC, an Evotec AG Company Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.11.5 Cyprotex PLC, an Evotec AG Company Recent Developments 7.12 Domainex 7.12.1 Domainex Profile 7.12.2 Domainex Main Business 7.12.3 Domainex Outsourcing Drug Discovery Products, Services and Solutions 7.12.4 Domainex Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.12.5 Domainex Recent Developments 7.13 Nanosyn, Inc. 7.13.1 Nanosyn, Inc. Profile 7.13.2 Nanosyn, Inc. Main Business 7.13.3 Nanosyn, Inc. Outsourcing Drug Discovery Products, Services and Solutions 7.13.4 Nanosyn, Inc. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.13.5 Nanosyn, Inc. Recent Developments 7.14 Olon Ricerca Biosciences 7.14.1 Olon Ricerca Biosciences Profile 7.14.2 Olon Ricerca Biosciences Main Business 7.14.3 Olon Ricerca Biosciences Outsourcing Drug Discovery Products, Services and Solutions 7.14.4 Olon Ricerca Biosciences Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.14.5 Olon Ricerca Biosciences Recent Developments 7.15 Pharmaron, Inc. 7.15.1 Pharmaron, Inc. Profile 7.15.2 Pharmaron, Inc. Main Business 7.15.3 Pharmaron, Inc. Outsourcing Drug Discovery Products, Services and Solutions 7.15.4 Pharmaron, Inc. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.15.5 Pharmaron, Inc. Recent Developments 7.16 TCG Lifesciences Pvt Ltd. 7.16.1 TCG Lifesciences Pvt Ltd. Profile 7.16.2 TCG Lifesciences Pvt Ltd. Main Business 7.16.3 TCG Lifesciences Pvt Ltd. Outsourcing Drug Discovery Products, Services and Solutions 7.16.4 TCG Lifesciences Pvt Ltd. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.16.5 TCG Lifesciences Pvt Ltd. Recent Developments 7.17 Viva Biotech, Ltd. 7.17.1 Viva Biotech, Ltd. Profile 7.17.2 Viva Biotech, Ltd. Main Business 7.17.3 Viva Biotech, Ltd. Outsourcing Drug Discovery Products, Services and Solutions 7.17.4 Viva Biotech, Ltd. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.17.5 Viva Biotech, Ltd. Recent Developments 7.18 WuXi AppTec Co. Ltd. 7.18.1 WuXi AppTec Co. Ltd. Profile 7.18.2 WuXi AppTec Co. Ltd. Main Business 7.18.3 WuXi AppTec Co. Ltd. Outsourcing Drug Discovery Products, Services and Solutions 7.18.4 WuXi AppTec Co. Ltd. Outsourcing Drug Discovery Revenue (US$ Million) & (2019-2024) 7.18.5 WuXi AppTec Co. Ltd. Recent Developments 8 Industry Chain Analysis 8.1 Outsourcing Drug Discovery Industrial Chain 8.2 Outsourcing Drug Discovery Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Outsourcing Drug Discovery Sales Model 8.5.2 Sales Channel 8.5.3 Outsourcing Drug Discovery Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
QYResearch 社の最新刊レポート本レポートと同じKEY WORD（）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/20 10:26 143.76 円 160.81 円 193.57 円 |